PEARRL
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
Picture

Dr. C. Saal
Merck Group, Molecule Characterisation, Germany

Picture

Position

Director – Site Operations – Analytical Biochemistry at Merck Group

Background

Dr. Saal got a Diploma and PhD in Physical Chemistry from the Technical University of Darmstadt. After starting his industrial career at Siemens, he joined Merck KGaA in 1999 where he worked in the central analytical department and in medicinal chemistry. His research interests focus on analytical characterization of new chemical entities including physico-chemical characterization of research compounds and development candidates.
Dr. Saal has a teaching assignment for pharmaceutical technology at the Johann-Wolfgang Goethe University. He is a member of several expert groups on analytical methods at the European Directorate for the Quality of Medicines.

Role in PEARRL

Main Supervisor ESR 3

Key Publications

  • S. Paulekuhn, J. Dressman, C. Saal: „Trends in Active Pharmaceutical Ingredient Salt Selection based on Analysis of the Orange Book Database“, J. Med. Chem., 2007, 50(26), 6665-6672.
  • B. Hoellke, M. Arlt, C. Saal, „Comparison of Nephelometric, UV-Spectroscopic and HPLC Methods for High-Throughput Determination of Aqueous Drug Solubility in Microtiter Plates“, Analytical Chemistry, 2009, 81(8), 3165-3172.
  • E. Widjaja, P. Kanaujia, G. Lau, W.-K. Ng, M. Garland, C. Saal, A. Hanefeld, M. Fischbach, M. Maio, B.H. Reginald, “Detection of trace crystallinity in an amorphous system using Raman microscopy and chemometric analyses”, European Journal of Pharmaceutical Sciences, 2011, 42(1-2), 45-54.
  • P. Kanaujjia, G. Lau, W.K. Ng, E. Widjaja, M. Schreyer, A. Hanefeld, M. Fischbach, C. Saal, M. Maio, R.B.H. Tan, “Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy”, Drug Developm. Ind. Pharm. 2011, 37(9), 1026-1035.
  • A. Petereit, C. Saal, “Optimizing Solubility: Kinetic versus Thermodynamic Solubility – Temptations and Risks” Eur. J. Pharm. Sci., 2012, 47(3), 589-595.
  • C. Saal, A. Becker, “Pharmaceutical Salts: A Review on Doses of Salt Formers form the Orange Book”, Eur. J. Pharm. Sci., 2013, 49(4), 614-623.
  • S. Paulekuhn, J.B. Dressmann, C. Saal, „Salt Screening and Characterization for poorly soluble, weak basic Compounds: Case Study Albendazole”, Die Pharmazie, 2013, 68, 555-564.
  • E. Hoppe, H.P. Buchstaller, H.M. Eggenweiler, C. Sirrenberg, A. Zimmermann, J. Maerz, H.Schwartz, C. Saal, M. Meyring, S. Hecht, “A novel strategy for ADME screening of prodrugs: Combined use of serum and hepatocytes to integrate bioactivation and clearance, and predict exposure to both active and prodrug to the systemic circulation”, J. Pharm. Sci, 2014, 103(5), 1504-1514.
  • C. Saal, A. Mieden, A. Marx, M. Vogtherr, “Investigation of solubilising effects of bile salts on an active pharmaceutical ingredient with unusual pH dependent solubility by NMR spectroscopy”, Eur. J. Pharm. Biopharm, 2015, 92, 32-41.
  • C. Saal, M. Lange, C. Kühn, H. Untenecker, A. Jonczyk, S. Petersen, G. Scholz, V. Buback, M. Dotzauer, H. Bauer, J. Förster, J. Schumacher, A. Metz, M. Schmidt, K. Seemann, „Cilengitide – Exceptional Pseudo-polymorphism of a Cyclic-Pentapeptide”, Eur. J. Pharm. Sci., 2015, 71, 1-11.
  • J. Dressman, E. Herbert, A. Wieber, G. Birk, C. Saal, D. Lubda, „Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate”, J. Pharm. Pharm., 2015, DOI: 10.1111/jphp.12465
Picture
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 674909.
Disclaimer | Member Area
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.